肠舒饮治疗习惯性便秘临床观察  

Clinical Observation on the Therapeutic Efficacy of Changshuyin Draft for Habitual Constipation

作　　者：陈明[1] 赵军超[1] 沈小峰[1] 沈燕[1] 

机构地区：[1]浙江省海盐县中医院肛肠科,浙江海盐314300

出　　处：《中国肛肠病杂志》2010年第1期26-27,共2页Chinese Journal of Coloproctology

基　　金：海盐县科技局立项课题编号：2008Y382011

摘　　要：为观察肠舒饮治疗习惯性便秘的临床疗效，将72例习惯性便秘（气血亏虚型）患者随机分为两组，治疗组38例采用肠舒饮治疗；对照组34例，予车前番泻颗粒治疗，观察两组用药后情况。结果显示，治疗组和对照组治疗两个疗程后的总有效率分别为92．11％和91．18％（P〉0．05），不良反应发生率分别为13．16％和35．29％（P〈0．05）。结果表明，肠舒饮治疗习惯性便秘疗效确切，且不良反应少，值得临床推广。The objective of this study was to observe the therapeutic efficacy of Changshuyin Draft in the treatment of habitual constipation. Seventy two patients with habitual constipation（the type of deficiency of qi and blood） were randomly divided into two groups; patients in the study group （ n = 38） underwent Changshuyin Draft,while patients in the controlled group （ n = 34） received Agiolax. Therapeutic evaluation was made after administration in the two groups. Results showed that the total improvement rate in the study group and controlled group was 92.11% and 91.18% （ P 〉0.05） respectively, and the adverse reaction rate was 13.16% and 35.29% （ P 〈0.05） respectively. It was concluded that Changshuyin Draft has exact effect in the treatment of habitual constipation, less of adverse reaction and was worthy to be popularized.

关 键 词：肠舒饮 习惯性便秘 临床观察 

分 类 号：R256.35[医药卫生—中医内科学] R735[医药卫生—中医学]